[18f]-fet-βag-toca
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 14, 2014 (NCT06456723)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06456723 | Phase 1/Phase 2 (Phase 2) | May 14, 2014 | Imperial College London, Invicro, Newcastle University, Royal Marsden Hospital NHS Trust, The Christie NHS Foundation Trust, University of London, University of Manchester |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Imperial College London | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Invicro | For profit | 1 | 0 | 1 | 2014 |
| Newcastle University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Royal Marsden Hospital NHS Trust | Academic/Hospital | 1 | 0 | 1 | 2014 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Manchester | Academic/Hospital | 1 | 0 | 1 | 2014 |
7 organizations
Page 1 / 1